Clinical Trial Update: Enhancement of Bone Regeneration and Healing in the Extremities by the Use of Autologous BonoFill-II [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating autologous BonoFill-II for enhanced bone regeneration and healing in extremities for bone fractures, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Fracture

Drugs mentioned

• BonoFill-II

Snippet

Sponsor: BonusBio Group Ltd | Conditions: Bone Fracture | Phase 1, Phase 2 | Status: RECRUITING